Wells Fargo Earnings Catch a Bad Case of COVID-19
Wells Fargo released a disappointing second-quarter earnings report and lowered its dividend before the opening bell on Tuesday.
All Work
Chris Lange
9 Top Tech Stocks Are Coronavirus Winners and Overvalued
24/7 Wall St. has picked out a handful of stocks that are the biggest winners from the pandemic thus far. Analysts are incredibly bullish on them all.
COVID-19 Testing Creates a Boom for LabCorp and Quest Diagnostics
One of the most important aspects of reopening the economy during this pandemic is testing for COVID-19. Credit Suisse sees a couple of winners benefitting incredibly from this.
Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track
Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus vaccine candidates received Fast Track Designation.
Lockdown Snacking Keeps PepsiCo Afloat
PepsiCo reported better than expected most recent quarterly results before the markets opened on Monday but noted that its fiscal 2020 guidance is no longer applicable.
Short Sellers Can’t Make Up Their Minds on Big Biotechs
The June 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Is Semiconductor Short Interest Signaling a Market Rally?
The June 30 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.
6 Big Banks Under Book Value Heading Into Earnings
Bank stocks traditionally kick off earnings season and play a large role in gauging the temperature for how the rest of the season may go.
Citigroup, Goldman Sachs, JPMorgan, Wells Fargo and More Big Banks Reporting This Week
24/7 Wall St. has put together a preview of Bank of America, Citigroup and some of the other major financial companies kicking off the new earnings reporting season.
Delta Air, Johnson & Johnson, Netflix, Pepsi and More Major Earnings This Week
Here, 24/7 Wall St. offers a preview of what to expect from Delta Air Lines, Netflix, PepsiCo and some of the other most anticipated quarterly results due this week.
Why Cell Phone and Data Towers Should See a Strong 2021 Despite Multiple Concerns
A report from SunTrust Robinson Humphrey details where the telecoms stand. Will 2021 produce growth similar to, if not better than, 2020?
Why Shopify Earnings Should Overshadow Amazon’s Earnings
Shopify and Amazon.com each have seen massive runs during the pandemic, but by the looks of it, Shopify could overshadow Amazon when it comes to earnings.
7 Video Game Stock Winners Ahead of New Console Launches
24/7 Wall St. reviews those companies that could stand to benefit from this upcoming video game console supercycle, including makers of the hardware and the games, as well as retailers.
Which 4 Cybersecurity Stocks Still Have the Most Upside and Opportunity?
Cybersecurity companies look to be in an increasingly promising field going forward. Here are some top picks in this industry with the most upside and opportunity.
It’s More Than Earnings Holding Back Walgreens
Walgreens Boots Alliance slid on Thursday after the company reported disappointing fiscal third-quarter financial results and guidance.
Will Bed Bath & Beyond Ever Recover From COVID-19?
Bed Bath & Beyond shares were crushed on Thursday after the company reported disappointing first-quarter results.
Why Dollar Stores Have More Upside Than Walmart and Costco
Big names like Walmart and Costco certainly will ride out the pandemic. Surprisingly, dollar stores appear to have a fighting chance too, and they could even offer more upside than the retail behemoths.
NanoViricides COVID-19 Treatment Offers Alternative to Antibodies
NanoViricides made another stride in the fight against COVID-19, and investors have to be happy about it.
Why Pfizer’s Stock Could Rise 60% or More
Pfizer is among the current frontrunners for a COVID-19 vaccine, so why is its stock down 13% year to date? And why does one independent research firm say this stock could run much higher?
Why This Analyst Sees Big Upside in COVID-19 Immunotherapy Study
After Corvus Pharmaceuticals announced that it would initiate an early-stage immunotherapy study in patients with COVID-19, Wedush sees this stock running much higher.